MXPA05010402A - Oxido nitrico en el tratamiento de la inflamacion. - Google Patents

Oxido nitrico en el tratamiento de la inflamacion.

Info

Publication number
MXPA05010402A
MXPA05010402A MXPA05010402A MXPA05010402A MXPA05010402A MX PA05010402 A MXPA05010402 A MX PA05010402A MX PA05010402 A MXPA05010402 A MX PA05010402A MX PA05010402 A MXPA05010402 A MX PA05010402A MX PA05010402 A MXPA05010402 A MX PA05010402A
Authority
MX
Mexico
Prior art keywords
nitric oxide
inflammation
treatment
mammal
medicament
Prior art date
Application number
MXPA05010402A
Other languages
English (en)
Inventor
Da Jiping
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of MXPA05010402A publication Critical patent/MXPA05010402A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El uso del oxido nitrico, en la forma de oxido nitrico gaseoso o un donador de oxido nitrico, en combinacion con un glucocorticoide para la fabricacion de un medicamento para el tratamiento de la inflamacion infecciosa en un mamifero, que incluye el hombre, dicha combinacion se usa en una cantidad terapeuticamente efectiva para efectuar el tratamiento de dicha inflamacion. Los metodos y una composicion farmaceutica para el tratamiento de la inflamacion. El uso del oxido nitrico, en la forma de oxido nitrico gaseoso o un donador de oxido nitrico, para la fabricacion de un medicamento para incrementar la expresion del receptor de glucocorticoide en las celulas de un mamifero, incluyendo el hombre. Un metodo para tal incremento.
MXPA05010402A 2003-04-03 2004-04-02 Oxido nitrico en el tratamiento de la inflamacion. MXPA05010402A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0300971A SE0300971D0 (sv) 2003-04-03 2003-04-03 Nitric oxide in treatment of inflammation
PCT/SE2004/000511 WO2004087212A2 (en) 2003-04-03 2004-04-02 Nitric oxide in treatment of inflammation

Publications (1)

Publication Number Publication Date
MXPA05010402A true MXPA05010402A (es) 2005-11-04

Family

ID=20290910

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010402A MXPA05010402A (es) 2003-04-03 2004-04-02 Oxido nitrico en el tratamiento de la inflamacion.

Country Status (11)

Country Link
US (2) US20050069595A1 (es)
EP (1) EP1608405A2 (es)
JP (1) JP2006522116A (es)
CN (1) CN1535692A (es)
AR (1) AR043968A1 (es)
AU (1) AU2004226520A1 (es)
CA (1) CA2521052A1 (es)
CL (1) CL2004000722A1 (es)
MX (1) MXPA05010402A (es)
SE (1) SE0300971D0 (es)
WO (1) WO2004087212A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
ATE531419T1 (de) * 2003-12-15 2011-11-15 Nitricare Hb Vorrichtung zur verabreichung von therapeutischen mitteln
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP3556401A1 (en) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
CN1990045B (zh) * 2005-12-30 2010-12-22 北京尼奥克斯生物科技有限公司 一种新型高效烧烫伤类贴剂及其制备方法
US8399005B2 (en) 2007-10-12 2013-03-19 University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US20100098733A1 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
BR112012008508A2 (pt) * 2009-10-13 2017-06-13 Novan Inc revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
US20120107423A1 (en) * 2010-11-01 2012-05-03 Ino Therapeutics Llc Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012093383A1 (en) * 2011-01-04 2012-07-12 Radikal Therapeutics Inc. Compositions and methods for treatment of sepsis and related conditions
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
WO2013132499A1 (en) * 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
EP3020438A1 (en) * 2014-11-13 2016-05-18 Linde AG Device for ventilating a patient and method for operating a device for ventilating a patient
WO2017130066A1 (en) * 2016-01-27 2017-08-03 Advanced Inhalation Therapies (Ait) Ltd. Methods of treatment of respiratory tract infections and cystic fibrosis
CN109069701A (zh) * 2016-02-25 2018-12-21 密歇根大学董事会 氧化氮产生制剂和试剂盒
EP3444615B1 (en) * 2017-08-15 2021-09-08 Freiberg Instruments GmbH Methods and compositions for diagnostic evaluation and therapeutic correction of the no-haem signalling pathway(s) in animals and humans

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69127756T2 (de) * 1990-12-05 1998-02-05 Gen Hospital Corp Verwendung von no zur behandlung oder prävention der bronchokonstriktion
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
DE4420523A1 (de) * 1994-06-13 1995-12-14 Cassella Ag Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen
WO1996002268A1 (en) * 1994-07-15 1996-02-01 Brigham And Women's Hospital Inhibition of virus by nitric oxide
AU5527196A (en) * 1995-04-04 1996-10-23 Brigham And Women's Hospital Inhibiting retroviral replication
US5985662A (en) * 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
IT1282686B1 (it) * 1996-02-26 1998-03-31 Nicox Sa Composti in grado di ridurre la tossicita' da farmaci
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
US5985562A (en) * 1997-06-03 1999-11-16 Schering Aktiengesellschaft Method of detecting thrombotic disease risk associated with plasma carboxypeptidase B polymorphisms
EP1011657A1 (en) * 1997-07-11 2000-06-28 The Johns Hopkins University School Of Medicine Nitric oxide inhibits rhinovirus infection
US6656452B1 (en) * 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms

Also Published As

Publication number Publication date
WO2004087212A2 (en) 2004-10-14
AR043968A1 (es) 2005-08-17
CL2004000722A1 (es) 2005-01-14
SE0300971D0 (sv) 2003-04-03
US20050069595A1 (en) 2005-03-31
CN1535692A (zh) 2004-10-13
EP1608405A2 (en) 2005-12-28
CA2521052A1 (en) 2004-10-14
WO2004087212A3 (en) 2004-12-16
AU2004226520A1 (en) 2004-10-14
US20080089956A1 (en) 2008-04-17
JP2006522116A (ja) 2006-09-28

Similar Documents

Publication Publication Date Title
MXPA05010402A (es) Oxido nitrico en el tratamiento de la inflamacion.
Heinlin et al. Randomized placebo‐controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
NZ604031A (en) Methods of treatment of pancreatic cancer
NZ610068A (en) Compositions comprising povidone-iodine
WO2005074913A3 (en) Compositions and methods for treating contracture
BRPI0516531A (pt) imunoterapia de distúrbios auto-imunes
WO2002043652A3 (en) Anti-proliferative drugs
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2008030538A3 (en) Cancer stem cell-targeted cancer therapy
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO2006068768A3 (en) Methods and compositions for treating conditions
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
SE0004229D0 (sv) Inhalation of nitric oxide
WO2007112453A3 (en) Methods amd compositions for treating conditions
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
NZ578065A (en) Methods for treating psoriasis with an antibody which binds to an epitope
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
WO2008079993A3 (en) Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
WO2004046309A3 (en) Methods for inhibiting viral replication in vivo
DK2014293T3 (da) Anvendelse af argon i gasformig tilstand til at behandle neurointoxikation
HK1127556A1 (en) Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
GB2456475A (en) Composition for the treatment of skin conditions

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: INO THERAPEUTICS LLC

FA Abandonment or withdrawal